Shares of Ampliphi Biosciences Corp (NYSEAMERICAN:APHB) saw unusually-high trading volume on Friday . Approximately 2,086,386 shares changed hands during trading, an increase of 48% from the previous session’s volume of 1,413,527 shares.The stock last traded at $1.15 and had previously closed at $1.09.

Separately, HC Wainwright set a $5.00 price target on shares of Ampliphi Biosciences and gave the company a “buy” rating in a research report on Monday, October 2nd.

The stock has a market cap of $10.16, a PE ratio of -0.11 and a beta of 2.93.

Ampliphi Biosciences (NYSEAMERICAN:APHB) last issued its earnings results on Tuesday, November 14th. The biotechnology company reported ($0.09) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.46) by $0.37. Ampliphi Biosciences had a negative net margin of 2,050.00% and a negative return on equity of 31.85%.

ILLEGAL ACTIVITY NOTICE: This news story was originally posted by Watch List News and is the property of of Watch List News. If you are viewing this news story on another publication, it was stolen and republished in violation of United States and international copyright laws. The correct version of this news story can be viewed at

Ampliphi Biosciences Company Profile

AmpliPhi Biosciences Corporation is a biotechnology company. The Company is focused on the discovery, development and commercialization of phage therapeutics. The Company is engaged in identifying, characterizing and developing naturally occurring bacteriophages with its collaboration partners in bacteriophage biology, synthetic biology and manufacturing, to develop second-generation bacteriophage products.

Receive News & Ratings for Ampliphi Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampliphi Biosciences and related companies with's FREE daily email newsletter.